LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes (vol 32, pg 91, 2018)

被引：0
|
作者：
Lamb, Yvette N. [1 ]
Syed, Yahiya Y. [1 ]
机构：
[1] Springer, Private Bag 65901, Auckland 0754, New Zealand
来源：
BIODRUGS | 2018年 / 32卷 / 02期
关键词：
D O I：
10.1007/s40259-018-0269-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Page 91, abstract, lines 1-6: The following sentence, which previously read:.
引用
收藏
页码：181 / 181
页数：1
相关论文
共 50 条
  • [1] LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes
    Lamb, Yvette N.
    Syed, Yahiya Y.
    [J]. BIODRUGS, 2018, 32 (01) : 91 - 98
  • [2] LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes
    Yvette N. Lamb
    Yahiya Y. Syed
    [J]. BioDrugs, 2018, 32 : 91 - 98
  • [3] Correction to: LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes
    Yvette N. Lamb
    Yahiya Y. Syed
    [J]. BioDrugs, 2018, 32 : 181 - 181
  • [4] Comment on: LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes
    Riccardo Perfetti
    [J]. BioDrugs, 2018, 32 : 177 - 177
  • [5] Comment on: LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes
    Perfetti, Riccardo
    [J]. BIODRUGS, 2018, 32 (02) : 177 - 177
  • [6] Efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine
    Hadjiyianni, I.
    Dahl, D.
    Lacaya, L. B.
    Pollom, R. K.
    Chang, C. L.
    Ilag, L. L.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (04): : 425 - 429
  • [7] Immunogenicity of LY2963016 insulin glargine and Lantus® insulin glargine in Chinese patients with type 1 or type 2 diabetes mellitus
    Wang, Weimin
    Song, Xiang
    Lou, Ying
    Du, Liying
    Zhu, Dalong
    Zhou, Zhiguang
    [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (06): : 1094 - 1104
  • [8] The efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine
    Hadjiyianni, I.
    Asaro-Harris, A.
    Dahl, D.
    Lacaya, L. B.
    Pollom, R. K.
    Ilag, L. L.
    Zielonka, J. S.
    [J]. DIABETOLOGIA, 2015, 58 : S469 - S469
  • [9] Evaluation of immunogenicity of LY2963016 insulin glargine compared with insulin glargine in patients with type 2 diabetes mellitus
    Ilag, L. L.
    Deeg, M. A.
    Huster, W. J.
    Costigan, T. M.
    Zielonka, J. S.
    Pollom, R. K.
    Prince, M. J.
    Konrad, R. J.
    [J]. DIABETOLOGIA, 2014, 57 : S397 - S398
  • [10] Authors' Reply to Dr. Riccardo Perfetti: "LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes"
    Lamb, Yvette N.
    Syed, Yahiya Y.
    [J]. BIODRUGS, 2018, 32 (02) : 179 - 179
12345